Terms: = Kidney tumors AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
55 results:
1. Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas.
Tang F; Wang X; Liu T; Wang H; Wan Z; Fu Q; Zheng Z; Aersi M; Peng J
Urol J; 2024 Mar; 21(2):107-113. PubMed ID: 38168059
[TBL] [Abstract] [Full Text] [Related]
2. Macrophage-derived exosomal miR-342-3p promotes the progression of renal cell carcinoma through the NEDD4L/CEP55 axis.
Feng J; Xu B; Dai C; Wang Y; Xie G; Yang W; Zhang B; Li X; Wang J
Oncol Res; 2021; 29(5):331-349. PubMed ID: 37305161
[TBL] [Abstract] [Full Text] [Related]
3. Reliability and Management Outcomes Following a Percutaneous Biopsy diagnosis of Oncocytoma: A 15-year Retrospective Analysis.
Chai JL; Alencar RO; Hirsch MS; Bhagavatula S; Bay CP; Siegmund S; Chang SL; Silverman SG
Radiology; 2023 Apr; 307(2):e221156. PubMed ID: 36692400
[TBL] [Abstract] [Full Text] [Related]
4. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
5. KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through ERK/akt Signaling Pathway.
Fan B; Niu Y; Zhang A; Wei S; Ma Y; Su J; Ren Z
Kidney Blood Press Res; 2022; 47(12):702-710. PubMed ID: 36260980
[TBL] [Abstract] [Full Text] [Related]
6. Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.
Li M; Liu G; Jin X; Guo H; Setrerrahmane S; Xu X; Li T; Lin Y; Xu H
Mol Cancer; 2022 Sep; 21(1):181. PubMed ID: 36117171
[TBL] [Abstract] [Full Text] [Related]
7. Beyond Wilms tumor: imaging findings and outcomes of rare renal tumors in children.
Ayaz E; Ozcan HN; Oguz B; Haliloglu M
Pediatr Radiol; 2022 Dec; 52(13):2557-2567. PubMed ID: 35760918
[TBL] [Abstract] [Full Text] [Related]
8. Emerging role of LINC00461 in cancer.
Zhang Q; Zhong C; Shen J; Chen S; Jia Y; Duan S
Biomed Pharmacother; 2022 Aug; 152():113239. PubMed ID: 35679722
[TBL] [Abstract] [Full Text] [Related]
9. Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents.
Spees LP; Dinan MA; Jackson BE; Baggett CD; Wilson LE; Greiner MA; Kaye DR; Zhang T; George DJ; Scales CD; Pritchard JE; Leapman M; Gross CP; Wheeler SB
Clin Genitourin Cancer; 2022 Oct; 20(5):e396-e405. PubMed ID: 35595633
[TBL] [Abstract] [Full Text] [Related]
10. Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC.
Huang R; Zhang C; Wang X; Zou X; Xiang Z; Wang Z; Gui B; Lin T; Hu H
Cancer Med; 2022 Nov; 11(21):3993-4004. PubMed ID: 35322581
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity.
Wang XT; Xia QY; Fang R; Zhang RS; Ye SB; Li R; Wang X; Lu ZF; Ma HH; Zhou XJ; He HY; Zhao M; Rao Q
Hum Pathol; 2022 May; 123():102-112. PubMed ID: 35192800
[TBL] [Abstract] [Full Text] [Related]
12. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract] [Full Text] [Related]
13. Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.
Spees LP; Wheeler SB; Jackson BE; Baggett CD; Wilson LE; Greiner MA; Kaye DR; Zhang T; George D; Scales CD; Pritchard JE; Leapman M; Gross CP; Dinan MA
Cancer Med; 2021 Oct; 10(19):6653-6665. PubMed ID: 34480518
[TBL] [Abstract] [Full Text] [Related]
14. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract] [Full Text] [Related]
15. Functions of circular RNAs in bladder, prostate and renal cell cancer (Review).
Yang L; Zou X; Zou J; Zhang G
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649838
[TBL] [Abstract] [Full Text] [Related]
16. The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract] [Full Text] [Related]
17. Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression.
Song Y; Wang M; Tong H; Tan Y; Hu X; Wang K; Wan X
Oncogene; 2021 Jan; 40(3):633-646. PubMed ID: 33208911
[TBL] [Abstract] [Full Text] [Related]
18. Disturbance of consciousness due to hyperammonemia and lactic acidosis during mFOLFOX6 regimen: Case report.
Fukuda M; Nabeta M; Muta T; Cho T; Shimamatsu Y; Shimotsuura Y; Fukami K; Takasu O
Medicine (Baltimore); 2020 Aug; 99(33):e21743. PubMed ID: 32872062
[TBL] [Abstract] [Full Text] [Related]
19. NKAP promotes renal cell carcinoma growth via akt/mTOR signalling pathway.
Ma Q; Hou L; Gao X; Yan K
Cell Biochem Funct; 2020 Jul; 38(5):574-581. PubMed ID: 32032976
[TBL] [Abstract] [Full Text] [Related]
20. Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma.
Song J; Song F; Liu K; Zhang W; Luo R; Tang Y; Ran L
Aging (Albany NY); 2019 Nov; 11(22):10316-10337. PubMed ID: 31743108
[TBL] [Abstract] [Full Text] [Related]
[Next]
